Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
J Infect Dis ; 225(9): 1621-1625, 2022 05 04.
Article in English | MEDLINE | ID: mdl-34453537

ABSTRACT

We adapted the RNA FISH Stellaris method to specifically detect the expression of Plasmodium genes by flow cytometry and ImageStream (Flow-FISH). This new method accurately quantified the erythrocytic forms of (1) Plasmodium falciparum and Plasmodium vivax and (2) the sexual stages of P vivax from patient isolates. ImageStream analysis of liver stage sporozoites using a combination of surface circumsporozoite protein (CSP), deoxyribonucleic acid, and 18S RNA labeling proved that the new Flow-FISH is suitable for gene expression studies of transmission stages. This powerful multiparametric single-cell method offers a platform of choice for both applied and fundamental research on the biology of malaria parasites.


Subject(s)
Malaria , Sporozoites , Animals , Gene Expression , Humans , Malaria/parasitology , Plasmodium falciparum/genetics , Plasmodium vivax/genetics , Protozoan Proteins/analysis , Protozoan Proteins/genetics , RNA
2.
Proc Natl Acad Sci U S A ; 116(35): 17498-17508, 2019 08 27.
Article in English | MEDLINE | ID: mdl-31413195

ABSTRACT

Transmission of Plasmodium falciparum involves a complex process that starts with the ingestion of gametocytes by female Anopheles mosquitoes during a blood meal. Activation of gametocytes in the mosquito midgut triggers "rounding up" followed by egress of both male and female gametes. Egress requires secretion of a perforin-like protein, PfPLP2, from intracellular vesicles to the periphery, which leads to destabilization of peripheral membranes. Male gametes also develop flagella, which assist in binding female gametes for fertilization. This process of gametogenesis, which is key to malaria transmission, involves extensive membrane remodeling as well as vesicular discharge. Phospholipase A2 enzymes (PLA2) are known to mediate membrane remodeling and vesicle secretion in diverse organisms. Here, we show that a P. falciparum patatin-like phospholipase (PfPATPL1) with PLA2 activity plays a key role in gametogenesis. Conditional deletion of the gene encoding PfPATPL1 does not affect P. falciparum blood stage growth or gametocyte development but reduces efficiency of rounding up, egress, and exflagellation of gametocytes following activation. Interestingly, deletion of the PfPATPL1 gene inhibits secretion of PfPLP2, reducing the efficiency of gamete egress. Deletion of PfPATPL1 also reduces the efficiency of oocyst formation in mosquitoes. These studies demonstrate that PfPATPL1 plays a role in gametogenesis, thereby identifying PLA2 phospholipases such as PfPATPL1 as potential targets for the development of drugs to block malaria transmission.


Subject(s)
Gametogenesis , Malaria, Falciparum/parasitology , Malaria, Falciparum/transmission , Phospholipases/metabolism , Plasmodium falciparum/physiology , Protozoan Proteins/metabolism , Computational Biology/methods , Humans , Life Cycle Stages , Phospholipases/genetics , Plasmodium falciparum/ultrastructure , Protozoan Proteins/genetics , Sequence Deletion
3.
Proc Natl Acad Sci U S A ; 113(17): 4717-22, 2016 Apr 26.
Article in English | MEDLINE | ID: mdl-27071116

ABSTRACT

The malaria-causing Plasmodium parasites are transmitted to vertebrates by mosquitoes. To support their growth and replication, these intracellular parasites, which belong to the phylum Apicomplexa, have developed mechanisms to exploit their hosts. These mechanisms include expropriation of small metabolites from infected host cells, such as purine nucleotides and amino acids. Heretofore, no evidence suggested that transfer RNAs (tRNAs) could also be exploited. We identified an unusual gene in Apicomplexa with a coding sequence for membrane-docking and structure-specific tRNA binding. This Apicomplexa protein-designated tRip (tRNA import protein)-is anchored to the parasite plasma membrane and directs import of exogenous tRNAs. In the absence of tRip, the fitness of the parasite stage that multiplies in the blood is significantly reduced, indicating that the parasite may need host tRNAs to sustain its own translation and/or as regulatory RNAs. Plasmodium is thus the first example, to our knowledge, of a cell importing exogenous tRNAs, suggesting a remarkable adaptation of this parasite to extend its reach into host cell biology.


Subject(s)
Erythrocytes/metabolism , Erythrocytes/parasitology , Plasmodium falciparum/physiology , Protozoan Infections/parasitology , Protozoan Proteins/metabolism , RNA, Transfer/metabolism , Animals , Apicomplexa/parasitology , Apicomplexa/pathogenicity , Cells, Cultured , Host-Pathogen Interactions/physiology , Malaria , Mice , Plasmodium falciparum/pathogenicity , Protein Transport , Protozoan Infections/metabolism
4.
Cell Microbiol ; 18(3): 399-412, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26347246

ABSTRACT

Export of most malaria proteins into the erythrocyte cytosol requires the Plasmodium translocon of exported proteins (PTEX) and a cleavable Plasmodium export element (PEXEL). In contrast, the contribution of PTEX in the liver stages and export of liver stage proteins is unknown. Here, using the FLP/FRT conditional mutatagenesis system, we generate transgenic Plasmodium berghei parasites deficient in EXP2, the putative pore-forming component of PTEX. Our data reveal that EXP2 is important for parasite growth in the liver and critical for parasite transition to the blood, with parasites impaired in their ability to generate a patent blood-stage infection. Surprisingly, whilst parasites expressing a functional PTEX machinery can efficiently export a PEXEL-bearing GFP reporter into the erythrocyte cytosol during a blood stage infection, this same reporter aggregates in large accumulations within the confines of the parasitophorous vacuole membrane during hepatocyte growth. Notably HSP101, the putative molecular motor of PTEX, could not be detected during the early liver stages of infection, which may explain why direct protein translocation of this soluble PEXEL-bearing reporter or indeed native PEXEL proteins into the hepatocyte cytosol has not been observed. This suggests that PTEX function may not be conserved between the blood and liver stages of malaria infection.


Subject(s)
Malaria/parasitology , Plasmodium berghei/pathogenicity , Protozoan Proteins/metabolism , Animals , Animals, Genetically Modified , Gene Expression Regulation/drug effects , Gene Knockdown Techniques , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Heat-Shock Proteins/metabolism , Host-Parasite Interactions , Liver/parasitology , Mice , Plasmodium berghei/genetics , Protein Transport/genetics , Protozoan Proteins/genetics , Tetracyclines/pharmacology
5.
Cell Microbiol ; 17(4): 542-58, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25329441

ABSTRACT

Plasmodium spp., which causes malaria, produces a histamine-releasing factor (HRF), an orthologue of mammalian HRF. Histamine-releasing factor produced by erythrocytic stages of the parasite is thought to play a role in the pathogenesis of severe malaria. Here, we show in a rodent model that HRF is not important during the erythrocytic but pre-erythrocytic phase of infection, which mainly consists in the transformation in the liver of the mosquito-injected parasite form into the erythrocyte-infecting form. Development of P. berghei ANKA cl15cy1 liver stages lacking HRF is impaired and associated with an early rise in systemic IL-6, a cytokine that strongly suppresses development of Plasmodium liver stages. The defect is rescued by injection of anti-IL-6 antibodies or infection in IL-6-deficient mice and parasite HRF is sufficient to decrease IL-6 synthesis, indicating a direct role of parasite HRF in reducing host IL-6. The target cells modulated by HRF for IL-6 production at early time points during liver infection are neutrophils. Parasite HRF is thus used to down-regulate a cytokine with anti-parasite activity. Our data also highlight the link between a prolonged transition from liver to blood-stage infection and reduced incidence of experimental cerebral malaria.


Subject(s)
Biomarkers, Tumor/metabolism , Host-Pathogen Interactions , Interleukin-6/antagonists & inhibitors , Liver/parasitology , Malaria/pathology , Plasmodium berghei/physiology , Animals , Disease Models, Animal , Liver/pathology , Mice , Mice, Knockout , Plasmodium berghei/growth & development , Plasmodium berghei/metabolism , Treatment Outcome , Tumor Protein, Translationally-Controlled 1
6.
Cell Microbiol ; 16(5): 768-83, 2014 May.
Article in English | MEDLINE | ID: mdl-24617597

ABSTRACT

Calcium is a key signalling molecule in apicomplexan parasites and plays an important role in diverse processes including gliding motility. Gliding is essential for the malaria parasite to migrate from the skin to the liver as well as to invade host tissues and cells. Here we investigated the dynamics of intracellular Ca(2+) in the motility of Plasmodium berghei sporozoites by live imaging and flow cytometry. We found that cytosolic levels of Ca(2+) increase when sporozoites are activated in suspension, which is sufficient to induce the secretion of integrin-like adhesins that are essential for gliding motility. By increasing intracellular Ca(2+) levels artificially with an ionophore, these adhesins are secreted onto the sporozoite surface, however, the parasite is not capable of gliding. A second level of Ca(2+) modulation was observed during attachment to and detachment from a solid substrate, leading to a further increase or a decrease in the cytoplasmic levels of Ca(2+) respectively. We also observed oscillations in the intracellular Ca(2+) level during gliding. Finally, an intracellular Ca(2+) chelator, an inhibitor of phosphoinositide-specific phospholipase C (PI-PLC), and an inhibitor of the inositol triphosphate (IP3) receptor blocked the rise in intracellular Ca(2+) , adhesin secretion, and motility of activated sporozoites, indicating that intracellular stores supply Ca(2+) during sporozoite gliding. Our study indicates that a rise in intracellular Ca(2+) is necessary but not sufficient to activate gliding, that Ca(2+) levels are modulated in several ways during motility, and that a PI-PLC/IP3 pathway regulates Ca(2+) release during the process of sporozoite locomotion.


Subject(s)
Calcium/analysis , Cytosol/chemistry , Locomotion , Plasmodium berghei/physiology , Sporozoites/physiology , Cell Adhesion , Flow Cytometry , Optical Imaging , Plasmodium berghei/chemistry , Sporozoites/chemistry
7.
J Biol Chem ; 288(46): 33336-46, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24089525

ABSTRACT

In their mammalian host, Plasmodium parasites have two obligatory intracellular development phases, first in hepatocytes and subsequently in erythrocytes. Both involve an orchestrated process of invasion into and egress from host cells. The Plasmodium SUB1 protease plays a dual role at the blood stage by enabling egress of the progeny merozoites from the infected erythrocyte and priming merozoites for subsequent erythrocyte invasion. Here, using conditional mutagenesis in P. berghei, we show that SUB1 plays an essential role at the hepatic stage. Stage-specific sub1 invalidation during prehepatocytic development showed that SUB1-deficient parasites failed to rupture the parasitophorous vacuole membrane and to egress from hepatocytes. Furthermore, mechanically released parasites were not adequately primed and failed to establish a blood stage infection in vivo. The critical involvement of SUB1 in both pre-erythrocytic and erythrocytic developmental phases qualifies SUB1 as an attractive multistage target for prophylactic and therapeutic anti-Plasmodium intervention strategies.


Subject(s)
Hepatocytes/parasitology , Malaria/metabolism , Plasmodium berghei/enzymology , Protozoan Proteins/metabolism , Subtilisins/metabolism , Vacuoles/parasitology , Animals , Hepatocytes/metabolism , Hepatocytes/pathology , Malaria/pathology , Malaria/therapy , Mice , Mutagenesis , Plasmodium berghei/genetics , Protozoan Proteins/genetics , Subtilisins/genetics , Vacuoles/metabolism , Vacuoles/pathology
8.
Sci Adv ; 10(17): eadm9281, 2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38657074

ABSTRACT

Critical aspects of physiology and cell function exhibit self-sustained ~24-hour variations termed circadian rhythms. In the liver, circadian rhythms play fundamental roles in maintaining organ homeostasis. Here, we established and characterized an in vitro liver experimental system in which primary human hepatocytes display self-sustained oscillations. By generating gene expression profiles of these hepatocytes over time, we demonstrated that their transcriptional state is dynamic across 24 hours and identified a set of cycling genes with functions related to inflammation, drug metabolism, and energy homeostasis. We designed and tested a treatment protocol to minimize atorvastatin- and acetaminophen-induced hepatotoxicity. Last, we documented circadian-dependent induction of pro-inflammatory cytokines when triggered by LPS, IFN-ß, or Plasmodium infection in human hepatocytes. Collectively, our findings emphasize that the phase of the circadian cycle has a robust impact on the efficacy and toxicity of drugs, and we provide a test bed to study the timing and magnitude of inflammatory responses over the course of infection in human liver.


Subject(s)
Circadian Rhythm , Hepatocytes , Inflammation , Liver , Humans , Hepatocytes/metabolism , Hepatocytes/drug effects , Inflammation/metabolism , Liver/metabolism , Acetaminophen/pharmacology , Atorvastatin/pharmacology , Cytokines/metabolism , Inactivation, Metabolic , Lipopolysaccharides/pharmacology , Gene Expression Profiling , Gene Expression Regulation , Cells, Cultured
9.
Nat Med ; 12(2): 220-4, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16429144

ABSTRACT

Plasmodium, the parasite that causes malaria, is transmitted by a mosquito into the dermis and must reach the liver before infecting erythrocytes and causing disease. We present here a quantitative, real-time analysis of the fate of parasites transmitted in a rodent system. We show that only a proportion of the parasites enter blood capillaries, whereas others are drained by lymphatics. Lymph sporozoites stop at the proximal lymph node, where most are degraded inside dendritic leucocytes, but some can partially differentiate into exoerythrocytic stages. This previously unrecognized step of the parasite life cycle could influence the immune response of the host, and may have implications for vaccination strategies against the preerythrocytic stages of the parasite.


Subject(s)
Malaria/transmission , Plasmodium/physiology , Animals , Anopheles/parasitology , Humans , Lymphatic Vessels/parasitology , Malaria/immunology , Malaria/parasitology , Mice , Mice, Hairless , Mice, Inbred C57BL , Movement , Plasmodium/genetics , Plasmodium/immunology , Plasmodium/pathogenicity , Rats , Rats, Inbred BN , Skin/parasitology , Sporozoites/immunology , Sporozoites/pathogenicity , Sporozoites/physiology
10.
Proc Natl Acad Sci U S A ; 107(43): 18640-5, 2010 Oct 26.
Article in English | MEDLINE | ID: mdl-20921402

ABSTRACT

The first step of Plasmodium development in vertebrates is the transformation of the sporozoite, the parasite stage injected by the mosquito in the skin, into merozoites, the stage that invades erythrocytes and initiates the disease. The current view is that, in mammals, this stage conversion occurs only inside hepatocytes. Here, we document the transformation of sporozoites of rodent-infecting Plasmodium into merozoites in the skin of mice. After mosquito bite, ∼50% of the parasites remain in the skin, and at 24 h ∼10% are developing in the epidermis and the dermis, as well as in the immunoprivileged hair follicles where they can survive for weeks. The parasite developmental pathway in skin cells, although frequently abortive, leads to the generation of merozoites that are infective to erythrocytes and are released via merosomes, as typically observed in the liver. Therefore, during malaria in rodents, the skin is not just the route to the liver but is also the final destination for many inoculated parasites, where they can differentiate into merozoites and possibly persist.


Subject(s)
Plasmodium berghei/growth & development , Plasmodium yoelii/growth & development , Skin/parasitology , Animals , Anopheles/parasitology , Dermis/parasitology , Epidermis/parasitology , Green Fluorescent Proteins/genetics , Hair Follicle/parasitology , Host-Parasite Interactions , Malaria/parasitology , Malaria/transmission , Merozoites/growth & development , Mice , Mice, Hairless , Mice, Inbred C57BL , Plasmodium berghei/genetics , Plasmodium berghei/pathogenicity , Plasmodium yoelii/genetics , Plasmodium yoelii/pathogenicity , Sporozoites/growth & development
11.
iScience ; 26(2): 105940, 2023 Feb 17.
Article in English | MEDLINE | ID: mdl-36718363

ABSTRACT

Malaria eradication requires the development of new drugs to combat drug-resistant parasites. We identified bisbenzylisoquinoline alkaloids isolated from Cocculus hirsutus that are active against Plasmodium falciparum blood stages. Synthesis of a library of 94 hemi-synthetic derivatives allowed to identify compound 84 that kills multi-drug resistant clinical isolates in the nanomolar range (median IC50 ranging from 35 to 88 nM). Chemical optimization led to compound 125 with significantly improved preclinical properties. 125 delays the onset of parasitemia in Plasmodium berghei infected mice and inhibits P. falciparum transmission stages in vitro (culture assays), and in vivo using membrane feeding assay in the Anopheles stephensi vector. Compound 125 also impairs P. falciparum development in sporozoite-infected hepatocytes, in the low micromolar range. Finally, by chemical pull-down strategy, we characterized the parasite interactome with trilobine derivatives, identifying protein partners belonging to metabolic pathways that are not targeted by the actual antimalarial drugs or implicated in drug-resistance mechanisms.

12.
Nat Commun ; 13(1): 4123, 2022 07 15.
Article in English | MEDLINE | ID: mdl-35840625

ABSTRACT

Plasmodium vivax is the most widespread human malaria parasite. Due to the presence of extravascular reservoirs and relapsing infections from dormant liver stages, P. vivax is particularly difficult to control and eliminate. Experimental research is hampered by the inability to maintain P. vivax cultures in vitro, due to its tropism for immature red blood cells (RBCs). Here, we describe a new humanized mice model that can support efficient human erythropoiesis and maintain long-lasting multiplication of inoculated cryopreserved P. vivax parasites and their sexual differentiation, including in bone marrow. Mature gametocytes were transmitted to Anopheles mosquitoes, which led to the formation of salivary gland sporozoites. Importantly, blood-stage P. vivax parasites were maintained after the secondary transfer of fresh or frozen infected bone marrow cells to naïve chimeras. This model provides a unique tool for investigating, in vivo, the biology of intraerythrocytic P. vivax.


Subject(s)
Anopheles , Malaria, Vivax , Animals , Anopheles/parasitology , Humans , Malaria, Vivax/parasitology , Mice , Neoplasm Recurrence, Local , Plasmodium vivax , Sporozoites
13.
PLoS Pathog ; 5(1): e1000270, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19165333

ABSTRACT

The final step during cell division is the separation of daughter cells, a process that requires the coordinated delivery and assembly of new membrane to the cleavage furrow. While most eukaryotic cells replicate by binary fission, replication of apicomplexan parasites involves the assembly of daughters (merozoites/tachyzoites) within the mother cell, using the so-called Inner Membrane Complex (IMC) as a scaffold. After de novo synthesis of the IMC and biogenesis or segregation of new organelles, daughters bud out of the mother cell to invade new host cells. Here, we demonstrate that the final step in parasite cell division involves delivery of new plasma membrane to the daughter cells, in a process requiring functional Rab11A. Importantly, Rab11A can be found in association with Myosin-Tail-Interacting-Protein (MTIP), also known as Myosin Light Chain 1 (MLC1), a member of a 4-protein motor complex called the glideosome that is known to be crucial for parasite invasion of host cells. Ablation of Rab11A function results in daughter parasites having an incompletely formed IMC that leads to a block at a late stage of cell division. A similar defect is observed upon inducible expression of a myosin A tail-only mutant. We propose a model where Rab11A-mediated vesicular traffic driven by an MTIP-Myosin motor is necessary for IMC maturation and to deliver new plasma membrane to daughter cells in order to complete cell division.


Subject(s)
Cytokinesis/genetics , Cytoskeletal Proteins/metabolism , Membrane Proteins/metabolism , rab GTP-Binding Proteins/physiology , Animals , Female , Mice , Myosins/metabolism , Plasmodium berghei/growth & development , Plasmodium falciparum/growth & development , Protozoan Proteins/metabolism , Toxoplasma/growth & development
14.
Nat Microbiol ; 3(11): 1224-1233, 2018 11.
Article in English | MEDLINE | ID: mdl-30349082

ABSTRACT

The circumsporozoite protein (CSP) is the major surface protein of malaria sporozoites (SPZs), the motile and invasive parasite stage inoculated in the host skin by infected mosquitoes. Antibodies against the central CSP repeats of different plasmodial species are known to block SPZ infectivity1-5, but the precise mechanism by which these effectors operate is not completely understood. Here, using a rodent Plasmodium yoelii malaria model, we show that sterile protection mediated by anti-P. yoelii CSP humoral immunity depends on the parasite inoculation into the host skin, where antibodies inhibit motility and kill P. yoelii SPZs via a characteristic 'dotty death' phenotype. Passive transfer of an anti-repeat monoclonal antibody (mAb) recapitulates the skin inoculation-dependent protection, in a complement- and Fc receptor γ-independent manner. This purified mAb also decreases motility and, notably, induces the dotty death of P. yoelii SPZs in vitro. Cytotoxicity is species-transcendent since cognate anti-CSP repeat mAbs also kill Plasmodium berghei and Plasmodium falciparum SPZs. mAb cytotoxicity requires the actomyosin motor-dependent translocation and stripping of the protective CSP surface coat, rendering the parasite membrane susceptible to the SPZ pore-forming-like protein secreted to wound and traverse the host cell membrane6. The loss of SPZ fitness caused by anti-P. yoelii CSP repeat antibodies is thus a dynamic process initiated in the host skin where SPZs either stop moving7, or migrate and traverse cells to progress through the host tissues7-9 at the eventual expense of their own life.


Subject(s)
Antibodies, Protozoan/pharmacology , Malaria/immunology , Plasmodium yoelii/immunology , Protozoan Proteins/immunology , Skin/parasitology , Animals , Antibodies, Monoclonal/pharmacology , Cell Movement/drug effects , Culicidae , Female , Mice , Plasmodium berghei/immunology , Plasmodium falciparum/immunology , Plasmodium yoelii/cytology , Pore Forming Cytotoxic Proteins/metabolism , Sporozoites/cytology , Sporozoites/immunology
15.
Nucleic Acids Res ; 33(20): e174, 2005 Nov 10.
Article in English | MEDLINE | ID: mdl-16284199

ABSTRACT

After the deciphering of the genome sequences of several Plasmodium species, efforts must turn to elucidating gene function and identifying essential gene products. However, random approaches are lacking and gene targeting is inefficient in Plasmodium. Here, we established shuttle transposon mutagenesis in Plasmodium berghei. We constructed a mini-Tn5 derivative that can transpose into parasite genes cloned in Escherichia coli, providing an efficient means of generating knockout fragments. A 10(4)-fold increase in frequencies of double-crossover homologous recombination in the parasite using a new electroporation technology permits to reproducibly generate pools of distinct mutants after transfection with mini-Tn5-interrupted sequences. The procedure opens the way to the systematic identification of essential genes in Plasmodium.


Subject(s)
DNA Transposable Elements , Mutagenesis, Insertional/methods , Plasmodium berghei/genetics , Animals , Cloning, Molecular , DNA, Protozoan/genetics , Electroporation , Escherichia coli/genetics , Genes, Protozoan , Recombination, Genetic , Transfection
16.
Bull Acad Natl Med ; 191(7): 1261-70; discussion 1271, 2007 Oct.
Article in French | MEDLINE | ID: mdl-18447048

ABSTRACT

Infection by Plasmodium, the causative agent of malaria, starts when the parasite, injected by a mosquito vector, reaches and invades the liver, where it transforms into a stage that is capable of infecting erythrocytes and that causes the symptoms and complications of the disease. This phase of the infection, called pre-erythrocytic stage, is the most elusive of the parasite's life cycle, yet it was identified more than fifty years ago as a primary target of vaccine strategies aimed at avoiding erythrocyte infection. Recently in vivo imaging in a rodent model revealed that the pre-erythrocytic phase is unexpectedly complex. In particular, it includes a component of lymphatic infection, thus altering our representation of how an immune response can be mounted against these parasite stages.


Subject(s)
Malaria/parasitology , Plasmodium/ultrastructure , Animals , Anopheles/parasitology , Disease Models, Animal , Erythrocytes/parasitology , Hepatocytes/parasitology , Humans , Insect Bites and Stings/parasitology , Insect Bites and Stings/pathology , Insect Vectors/parasitology , Lymph Nodes/parasitology , Malaria/blood , Malaria/immunology , Malaria/prevention & control , Malaria/transmission , Mice , Plasmodium/growth & development , Plasmodium/physiology , Plasmodium berghei/ultrastructure , Vaccination/methods
17.
Sci Rep ; 7(1): 9129, 2017 08 22.
Article in English | MEDLINE | ID: mdl-28831137

ABSTRACT

While most subunit malaria vaccines provide only limited efficacy, pre-erythrocytic and erythrocytic genetically attenuated parasites (GAP) have been shown to confer complete sterilizing immunity. We recently generated a Plasmodium berghei (PbNK65) parasite that lacks a secreted factor, the histamine releasing factor (HRF) (PbNK65 hrfΔ), and induces in infected mice a self-resolving blood stage infection accompanied by a long lasting immunity. Here, we explore the immunological mechanisms underlying the anti-parasite protective properties of the mutant PbNK65 hrfΔ and demonstrate that in addition to an up-regulation of IL-6 production, CD4+ but not CD8+ T effector lymphocytes are indispensable for the clearance of malaria infection. Maintenance of T cell-associated protection is associated with the reduction in CD4+PD-1+ and CD8+PD-1+ T cell numbers. A higher number of central and effector memory B cells in mutant-infected mice also plays a pivotal role in protection. Importantly, we also demonstrate that prior infection with WT parasites followed by a drug cure does not prevent the induction of PbNK65 hrfΔ-induced protection, suggesting that such protection in humans may be efficient even in individuals that have been infected and who repeatedly received antimalarial drugs.


Subject(s)
Biomarkers, Tumor/genetics , Host-Parasite Interactions , Immunologic Memory , Malaria/immunology , Malaria/parasitology , Plasmodium/genetics , Plasmodium/immunology , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cytokines , Disease Models, Animal , Erythrocytes/immunology , Erythrocytes/parasitology , Female , Gene Expression , Life Cycle Stages , Mice , Plasmodium/growth & development , Programmed Cell Death 1 Receptor/genetics , Programmed Cell Death 1 Receptor/metabolism , Sequence Deletion , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Tumor Protein, Translationally-Controlled 1
18.
C R Biol ; 329(11): 858-62, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17067928

ABSTRACT

Malaria, the disease caused by Plasmodium, kills more than 1 million people annually. Little is known of the pre-erythrocytic phase of the parasite life cycle, i.e., after the sporozoite stage is inoculated in the dermis by a mosquito and before the erythrocyte-infecting stage is released from hepatocytes. We present here a quantitative, real-time analysis of the fate of parasites transmitted in a rodent system. We describe previously unrecognized steps in the parasite's journey to the liver of the host, which are likely to play an important role in the host immune response.


Subject(s)
Malaria/immunology , Malaria/parasitology , Plasmodium/physiology , Sporozoites/physiology , Animals , Computer Systems , Culicidae/parasitology , Dermis/parasitology , Humans , Liver/parasitology , Lymph Nodes/parasitology , Mice , Mice, Hairless , Plasmodium/growth & development , Sporozoites/growth & development
19.
J Exp Med ; 213(8): 1419-28, 2016 07 25.
Article in English | MEDLINE | ID: mdl-27432939

ABSTRACT

Although most vaccines against blood stage malaria in development today use subunit preparations, live attenuated parasites confer significantly broader and more lasting protection. In recent years, Plasmodium genetically attenuated parasites (GAPs) have been generated in rodent models that cause self-resolving blood stage infections and induce strong protection. All such GAPs generated so far bear mutations in housekeeping genes important for parasite development in red blood cells. In this study, using a Plasmodium berghei model compatible with tracking anti-blood stage immune responses over time, we report a novel blood stage GAP that lacks a secreted factor related to histamine-releasing factor (HRF). Lack of HRF causes an IL-6 increase, which boosts T and B cell responses to resolve infection and leave a cross-stage, cross-species, and lasting immunity. Mutant-induced protection involves a combination of antiparasite IgG2c antibodies and FcγR(+) CD11b(+) cell phagocytes, especially neutrophils, which are sufficient to confer protection. This immune-boosting GAP highlights an important role of opsonized parasite-mediated phagocytosis, which may be central to protection induced by all self-resolving blood stage GAP infections.


Subject(s)
Biomarkers, Tumor/genetics , Malaria , Plasmodium berghei , Protozoan Proteins , T-Lymphocytes/immunology , Animals , Antibodies, Protozoan/immunology , B-Lymphocytes/immunology , Disease Models, Animal , Female , Immunoglobulin G/immunology , Interleukin-6/immunology , Malaria/genetics , Malaria/immunology , Mice , Neutrophils/immunology , Phagocytosis/immunology , Plasmodium berghei/genetics , Plasmodium berghei/immunology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Tumor Protein, Translationally-Controlled 1
20.
Cell Host Microbe ; 20(5): 618-630, 2016 Nov 09.
Article in English | MEDLINE | ID: mdl-27832590

ABSTRACT

Surface-associated TRAP (thrombospondin-related anonymous protein) family proteins are conserved across the phylum of apicomplexan parasites. TRAP proteins are thought to play an integral role in parasite motility and cell invasion by linking the extracellular environment with the parasite submembrane actomyosin motor. Blood stage forms of the malaria parasite Plasmodium express a TRAP family protein called merozoite-TRAP (MTRAP) that has been implicated in erythrocyte invasion. Using MTRAP-deficient mutants of the rodent-infecting P. berghei and human-infecting P. falciparum parasites, we show that MTRAP is dispensable for erythrocyte invasion. Instead, MTRAP is essential for gamete egress from erythrocytes, where it is necessary for the disruption of the gamete-containing parasitophorous vacuole membrane, and thus for parasite transmission to mosquitoes. This indicates that motor-binding TRAP family members function not just in parasite motility and cell invasion but also in membrane disruption and cell egress.


Subject(s)
Erythrocytes/parasitology , Exocytosis , Merozoites/physiology , Plasmodium berghei/physiology , Plasmodium falciparum/physiology , Protozoan Proteins/metabolism , Vacuoles/parasitology , Animals , Culicidae , Humans , Membranes/metabolism , Mice
SELECTION OF CITATIONS
SEARCH DETAIL